Bioventus (BVS) vs Integra LifeSciences (IART)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
Bioventus (BVS) has outperformed Integra LifeSciences (IART) over the past year, gaining 92.0% versus a loss of 9.9%. Over five years, BVS leads with a -6.4% price change compared with -80.8% for IART. Integra LifeSciences is the larger company by market cap ($1.01 billion vs $872.3 million), about 1.2 times the size.
On valuation, Integra LifeSciences trades at a lower forward P/E (5.0x vs 13.9x for Bioventus).
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BVS | IART |
|---|---|---|
| Share price | $12.77 | $13.00 |
| Market cap | $872.26M | $1.01B |
| 1-day change | -2.52% | -2.40% |
| YTD return | +71.64% | +4.67% |
| 1-year return | +92.03% | -9.91% |
| 5-year return | -6.38% | -80.79% |
| P/E ratio (TTM) | 16.80 | — |
| Forward P/E | 13.88 | 5.00 |
| EPS (TTM) | $0.76 | $-0.09 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $15.89 | $20.49 |
| 52-week low | $6.37 | $8.70 |
| Distance from 52-week high | -19.65% | -36.55% |
| Average volume | 627.38K | 897.40K |
| Shares outstanding | 68.31M | 77.77M |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- BVS has outperformed IART by 101.9 percentage points over the past year.
BVS vs IART FAQ
Which is bigger, Bioventus or Integra LifeSciences?
Integra LifeSciences (IART) is larger, with a market capitalization of $1.01B compared with $872.26M for Bioventus (BVS).
Which stock has performed better over the past year, BVS or IART?
BVS returned +92.03% over the past 12 months, compared with -9.91% for IART (price return, excluding dividends). Past performance does not predict future results.
Are Bioventus and Integra LifeSciences in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.